Purpose: To describe the risk factors for epidural abscess (EA) formation following epidural analgesia in a parturient with pruritic urticarial papules and plaques of pregnancy (PUPPP). Clinical Features: A 33 yr-old gravida 2 nulliparous patient at 36 weeks gestation presented with severe pre-eclampsia, and PUPPP (treated with prednisone). Magnesium prophylaxis was started and labour was induced. An epidural catheter was placed at the L 3-4 level using standard aseptic technique. Bupivacaine was incrementally injected to achieve a T 10 sensory level, and analgesia was maintained using a continuous infusion of 0.0625% bupivacaine with fentanyl. Nine days post-delivery, the patient developed back pain radiating to her right leg, but she was otherwise asymptomatic. She was afebrile; with a slightly tender, nonerythematous, non-draining, 1 cm nodule at the epidural catheter site. Motor and sensory examinations were normal at that time. However, the patient returned 24 hr later and further investigations revealed: WBC 17,800·mm . The magnetic resonance imaging demonstrated an EA at the L 3-4 level causing minimal cord compression. The patient underwent an emergency decompressive laminectomy. Cultures revealed methicillin-sensitive Staphylococcus aureus. Her pain improved, and she was discharged on the third postoperative day with a six-week course of iv ceftriaxone. Conclusion: Causative organisms for EAs include coagulasenegative Staphylococci, S. aureus, and Gram-negative bacilli. Infection can occur either hematogenously or by direct contamination during catheter placement. Risk factors include immunocompromised states and PUPPP, as with the case of this patient.
Objectif : Décrire les facteurs de risque d'abcès péridural (AP) à la suite d'une analgésie péridurale chez une parturiente qui présente des papules et des plaques prurigineuses urticariennes de la grossesse (PPPUG).
Éléments cliniques : Une femme de 33 ans, nullipare, secondigeste, a consulté pour une sévère pré-éclampsie et des PPPUG (traitées avec de la prednisone) à 36 semaines de grossesse. L'administration préventive de magnésium a été amorcée et le travail induit. Un cathéter péridural a été placé à L3-4 selon la tech